EU industry asks commission to allow DEHP use in medical devices under REACH
This article was originally published in RAJ Devices
The European medtech industry has expressed concern over the European Commission’s proposal to place strict restrictions on the phthalate DEHP – a plasticiser commonly used in some medical devices1.
You may also be interested in...
Five new drugs have been recommended for EU approval at the latest meeting of European Medicines Agency’s drug evaluation committee.
The European Commission has set aside, for now, concerns expressed by member states regarding the scope of medicines subjected to additional monitoring requirements.
A new work sharing pilot has been launched to evaluate jointly generic drugs intended for launch in Singapore and Malaysia.